---
figid: PMC6368395__nihms-1516955-f0003
figtitle: Immunosuppressive agent-induced cell-intrinsic tumorigenic pathways
organisms:
- Hepatitis B virus
- Human gammaherpesvirus 4
- Human papillomavirus
- Human gammaherpesvirus 8
- Hepacivirus
- Homo sapiens
- NA
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6368395
filename: nihms-1516955-f0003.jpg
figlink: pmc/articles/PMC6368395/figure/F3/
number: F3
caption: 'Right: RTK c-Met-mediated signaling promotes the activation of Ras-Raf-MAPK
  pathways and the nuclear translocation of Nrf2, leading to overexpression of HO-1.
  CNI enhances c-Met-induced Ras activation and HO-1 expression. CNI inhibits RKIP
  and carabin, the negative regulators of Ras, and contributes to sustained Ras activation
  in cancer cells. CNI promotes the expression of ATF3, and it can inhibit p53-mediated
  apoptotic pathways. Center: CNI increases the expression of VEGF via PI3K-Akt-mTORC1
  pathway channeled through HIFs. CNI-induced Ras-Raf-PKC-ζ activation inhibits PRAS40,
  the negative regulator of mTORC1, and augments mTORC1 activity. CNI treatment increases
  the expression of TGF-β, IL-6, and CXCR3-A (the growth promoting CXCR3 isoform).
  Left: IL-6-mediated signaling activates JAK-STAT3 pathway. Together, CNI-induced
  signaling activates cell-intrinsic pro-tumorigenic pathways.'
papertitle: Signaling Molecules in Post-Transplantation Cancer.
reftext: Murugabaskar Balan, et al. Clin Lab Med. ;39(1):171-183.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9564781
figid_alias: PMC6368395__F3
figtype: Figure
redirect_from: /figures/PMC6368395__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6368395__nihms-1516955-f0003.html
  '@type': Dataset
  description: 'Right: RTK c-Met-mediated signaling promotes the activation of Ras-Raf-MAPK
    pathways and the nuclear translocation of Nrf2, leading to overexpression of HO-1.
    CNI enhances c-Met-induced Ras activation and HO-1 expression. CNI inhibits RKIP
    and carabin, the negative regulators of Ras, and contributes to sustained Ras
    activation in cancer cells. CNI promotes the expression of ATF3, and it can inhibit
    p53-mediated apoptotic pathways. Center: CNI increases the expression of VEGF
    via PI3K-Akt-mTORC1 pathway channeled through HIFs. CNI-induced Ras-Raf-PKC-ζ
    activation inhibits PRAS40, the negative regulator of mTORC1, and augments mTORC1
    activity. CNI treatment increases the expression of TGF-β, IL-6, and CXCR3-A (the
    growth promoting CXCR3 isoform). Left: IL-6-mediated signaling activates JAK-STAT3
    pathway. Together, CNI-induced signaling activates cell-intrinsic pro-tumorigenic
    pathways.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL6
  - SOS1
  - MET
  - IL6R
  - PEBP1
  - KRAS
  - HRAS
  - NRAS
  - NT5C1A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TBC1D10C
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - AKT1
  - AKT2
  - AKT3
  - AKT1S1
  - GABPA
  - NFE2L2
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - ATF3
  - MTOR
  - RPTOR
  - TP53
  - TP63
  - TP73
  - HMOX1
  - TGFB1
  - TGFB2
  - TGFB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CXCR3
  - ras
  - Ras64B
  - Ras85D
  - cni
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - hop
  - bsk
  - Akt
  - Nplp1
  - PRAS40
  - Keap1
  - cnc
  - NFAT
  - Atf3
  - raptor
  - Crtc
  - p53
  - betaTub60D
  - hth
  - dpp
  - gbb
  - put
  - mav
  - Ho
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - f------------------------
  - Cancer
---
